查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1647819

毛细血管采血设备市场 - 全球产业规模、份额、趋势、机会和预测，按产品、材料、最终用途、应用、地区和竞争细分，2020-2030 年

Capillary Blood Collection Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Material, By End Use, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球毛细血管采血设备市场价值为 26.4 亿美元，预计到 2030 年将达到 41.3 亿美元，预测期内复合年增长率为 7.68%。全球毛细血管采血设备市场的发展受到微创诊断程序需求不断增长、早期疾病检测意识不断增强以及糖尿病等慢性疾病增多的推动。糖尿病发生率在全球范围内迅速上升，中东和非洲地区的糖尿病发病率上升尤为令人担忧。国际糖尿病联盟(IDF) 预测，中东和北非地区的糖尿病病例将增加110%，而到2045 年，非洲地区的糖尿病病例预计将增加156%。受欢迎因为它们易于使用、经济高效、并且能够快速提供结果。科技的进步正在提高这些设备的精确度和效率，促进其在家庭护理和护理点环境中的采用。人们对自我检测的偏好日益增长，加上对个人化医疗保健解决方案的需求不断增长，也促进了市场的成长。人们对远端监控和医疗保健可近性的日益关注进一步加速了各个地区对毛细血管采血装置的需求。

市场概况
预测期 2026-2030
2024 年市场规模 26.4 亿美元
2030 年市场规模 41.3 亿美元
2025-2030 年复合年增长率 7.68％
成长最快的领域 刺血针
最大的市场 北美洲

主要市场驱动因素

慢性病盛行率上升

成本效益和可近性

技术进步与创新

新兴市场医疗保健基础设施和意识不断增强

转向预防性医疗保健

主要市场挑战

监理挑战与合规性

设备和实践缺乏标准化

主要市场趋势

日益普及即时诊断

家庭医疗保健和自我监测需求增加

分段洞察

产品洞察

最终用途洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球毛细血管采血设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品（采血针、微容器管、微量血球比容管、加温装置等）
    • 依材质（塑胶、玻璃、不锈钢、陶瓷等）
    • 依最终用途（医院和诊所、捐血中心、诊断中心、家庭诊断和病理实验室）
    • 按应用（全血、血浆/血清蛋白测试、综合代谢组 (CMP) 测试、肝功能组/肝功能分析/肝功能测试和干血斑测试）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第 6 章：北美毛细血管采血设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品
    • 按材质
    • 按最终用途
    • 按应用
    • 按国家
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲毛细血管采血设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品
    • 按材质
    • 按最终用途
    • 按应用
    • 按国家
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区毛细血管采血设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品
    • 按材质
    • 按最终用途
    • 按应用
    • 按国家
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲毛细血管采血设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品
    • 按材质
    • 按最终用途
    • 按应用
    • 按国家
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲毛细血管采血设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品
    • 按材质
    • 按最终用途
    • 按应用
    • 按国家
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如果有）
  • 最新动态

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Becton, Dickinson and Company
  • Greiner Bio-One International GmbH
  • Sarstedt Ag & Co. KG
  • Terumo Medical Corporation
  • B. Braun Melsungen AG
  • Guangzhou Improve Medical Instruments Co., Ltd
  • Abbott Laboratories Inc.
  • Cardinal Health, inc
  • Retractable Technologies, Inc.
  • Haemonetics Corporation

第 15 章：策略建议

第16章 调査会社について・免责事项

简介目录
Product Code: 27308

Global Capillary Blood Collection Devices Market was valued at USD 2.64 Billion in 2024 and is expected to reach USD 4.13 Billion by 2030 with a CAGR of 7.68% during the forecast period. The global Capillary Blood Collection Devices market is driven by increasing demand for minimally invasive diagnostic procedures, growing awareness of early disease detection, and the rise in chronic diseases such as diabetes. Diabetes is rapidly increasing worldwide, with the Middle East and Africa witnessing a particularly concerning surge. The International Diabetes Federation (IDF) predicts that the Middle East and North Africa will see a 110% rise in diabetes cases, while Africa is expected to experience a 156% increase by 2045.Capillary blood collection methods, like fingerstick testing, are gaining popularity due to their ease of use, cost-effectiveness, and ability to provide rapid results. Advancements in technology are improving the precision and efficiency of these devices, boosting their adoption in home care and point-of-care settings. The increasing preference for self-testing, coupled with the growing demand for personalized healthcare solutions, is also contributing to market growth. The rising focus on remote monitoring and healthcare accessibility further accelerates the demand for capillary blood collection devices across various regions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.64 Billion
Market Size 2030USD 4.13 Billion
CAGR 2025-20307.68%
Fastest Growing SegmentLancets
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases, particularly diabetes, cardiovascular diseases, and other metabolic disorders, is a primary driver of the Global Capillary Blood Collection Devices Market. Diabetes, which requires continuous monitoring of blood glucose levels, is one of the leading causes driving the demand for capillary blood collection devices. According to WHO, in 2021, noncommunicable diseases (NCDs) were responsible for at least 43 million deaths, accounting for 75% of non-pandemic-related global fatalities. Of these, 18 million people died from an NCD before reaching the age of 70, with 82% of these premature deaths occurring in low- and middle-income countries. Overall, 73% of all NCD-related deaths took place in these regions. Cardiovascular diseases were the leading cause of NCD deaths, accounting for at least 19 million deaths in 2021, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million, including kidney disease deaths linked to diabetes). Together, these four categories contributed to 80% of all premature NCD deaths. Factors such as tobacco use, physical inactivity, harmful alcohol consumption, poor diets, and air pollution increase the risk of dying from an NCD. Key strategies in addressing NCDs include early detection, screening, treatment, and palliative care.

As the global diabetes epidemic grows, particularly in aging populations and regions with high rates of obesity and sedentary lifestyles, more individuals require frequent blood testing to manage their conditions effectively. Capillary blood collection methods, such as lancets used for fingerstick testing, provide a fast and simple solution for patients to measure blood glucose levels at home without needing to visit healthcare facilities. The global aging population further contributes to this rise, as older adults are more prone to chronic conditions that require regular monitoring. Chronic diseases like hypertension and high cholesterol, which often coexist with diabetes, also require routine testing, further driving the demand for accessible and efficient blood collection methods. Consequently, the need for capillary blood collection devices is directly correlated with the increasing prevalence of chronic diseases, as these devices enable patients to perform self-testing and receive timely information about their health, ensuring better disease management and improved outcomes.

Cost-Effectiveness and Accessibility

The cost-effectiveness and accessibility of capillary blood collection devices are crucial factors driving the market's growth. Capillary blood collection devices are generally more affordable than traditional venous blood collection methods, making them more accessible to a broader range of individuals, especially in low- and middle-income countries. The devices are simple to use, portable, and require less training, making them suitable for home healthcare, remote locations, and emergency settings. In addition to being cost-effective, capillary blood collection devices are also more time-efficient, providing quick results without the need for specialized healthcare personnel or laboratory infrastructure. This accessibility is a key factor in expanding their adoption across various segments of the population, especially in areas with limited access to healthcare services. As the demand for affordable healthcare solutions increases globally, the accessibility and affordability of capillary blood collection devices are expected to remain significant drivers of the market.

Technological Advancements & Innovation

Technological advancements and continuous innovations in capillary blood collection devices are major contributors to the growth of the Global Capillary Blood Collection Devices Market. In July 2022, Rhinostics introduced the VERIstic Collection Device, designed to enable faster capillary blood collection. The device is equipped with an integrated cap, which streamlines the process and saves time.

The development of new, more efficient, and user-friendly devices is enhancing the adoption rate of these products. For example, the design of lancet devices has evolved significantly over the years, with improvements such as automatic depth adjustment, which reduces the discomfort associated with blood collection. There has been a focus on making devices more ergonomic and less invasive, providing patients with a more comfortable experience. Advancements in accuracy and precision are also contributing to the growth of the market. Devices are now capable of offering more reliable results with minimal blood samples, which is essential for monitoring chronic conditions such as diabetes, where accuracy is crucial for effective treatment. The introduction of connected devices that sync with mobile apps or cloud-based platforms for real-time data tracking further enhances their appeal. These innovations enable healthcare professionals and patients to track health data remotely, leading to more informed decisions and better disease management. The integration of smart technologies into blood collection devices is also opening up new opportunities for market expansion, as it allows for continuous monitoring and early detection of health issues. As these technologies evolve, they make capillary blood collection devices more efficient, accessible, and user-friendly, driving market growth.

Growing Healthcare Infrastructure and Awareness in Emerging Markets

The expansion of healthcare infrastructure and the rising awareness about chronic diseases in emerging markets such as Asia Pacific, South America, and the Middle East & Africa are contributing significantly to the growth of the Global Capillary Blood Collection Devices Market. Many emerging economies are seeing rapid urbanization, improvements in healthcare systems, and rising healthcare spending. As a result, more individuals in these regions are gaining access to healthcare products and services that were previously limited. With rising income levels and better healthcare access, people in these regions are more likely to invest in self-monitoring solutions, such as capillary blood collection devices, to manage their health. Healthcare awareness in these regions is on the rise, with governments and NGOs increasingly focusing on educating the population about the importance of early disease detection and management, particularly for chronic conditions like diabetes and hypertension. As these regions experience higher rates of chronic disease prevalence, there is a growing demand for cost-effective, easy-to-use diagnostic tools, fueling the adoption of capillary blood collection devices. Healthcare providers in these regions are becoming more aware of the need for regular monitoring and are recommending self-testing solutions for patients, further driving the market. As awareness continues to rise, the demand for capillary blood collection devices in emerging markets is expected to increase significantly in the coming years.

Shift Toward Preventive Healthcare

The global shift toward preventive healthcare is playing an essential role in expanding the Global Capillary Blood Collection Devices Market. Preventive healthcare focuses on disease prevention, early detection, and improving overall health outcomes, which requires regular health monitoring. Capillary blood collection devices enable individuals to perform frequent health checks, such as blood glucose monitoring, cholesterol testing, and other screenings that can identify risk factors for chronic diseases. As healthcare systems worldwide move from a reactive to a proactive approach, the demand for easy-to-use, reliable self-testing devices is growing. The rise in preventive healthcare is supported by initiatives from governments, insurance companies, and healthcare providers who are increasingly encouraging individuals to take control of their health through regular monitoring. For example, many health insurance providers offer discounts or incentives to individuals who regularly monitor their health metrics. This shift towards proactive health management, combined with the ease and affordability of capillary blood collection devices, is a significant factor driving the market. As more people adopt preventive healthcare practices, the demand for home-based monitoring tools like capillary blood collection devices is expected to grow.

Key Market Challenges

Regulatory Challenges and Compliance

One of the key challenges facing the Global Capillary Blood Collection Devices Market is the complex regulatory environment that governs the approval, distribution, and use of medical devices. Regulatory standards vary widely across different regions, and meeting the requirements of agencies like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other local regulatory bodies can be a lengthy and costly process. Ensuring compliance with stringent safety and quality standards is essential, but can be particularly challenging for manufacturers looking to enter emerging markets, where regulations may be less defined or constantly evolving. Any deviations in compliance or regulatory approval could lead to product recalls or delays in market entry, significantly affecting the financial performance of companies in the sector. The cost and time involved in obtaining regulatory approvals can limit the pace of innovation and product rollout, especially for smaller companies trying to compete with established industry leaders.

Lack of Standardization in Devices & Practices

Despite the growth of the Global Capillary Blood Collection Devices Market, there is still a lack of standardization in device designs and blood collection practices, which can impact the reliability and accuracy of results. Capillary blood collection devices are often used in diverse healthcare settings, from home care to hospitals, and inconsistency in device quality and usage can result in variations in test results. For example, the lancet depth, the angle of the blood collection, and the site of the puncture can influence the sample quality. Healthcare professionals may use devices incorrectly, leading to inadequate blood samples and affecting diagnosis. This lack of standardization creates challenges in ensuring that devices meet consistent performance benchmarks, which is critical in diagnostic applications, particularly for conditions like diabetes where accurate monitoring is essential for effective disease management. The absence of universally accepted guidelines for capillary blood collection further exacerbates this issue, making it more difficult for healthcare providers to rely on these devices for consistent results across different patient groups.

Key Market Trends

Increasing Adoption of Point-of-Care Diagnostics

The growing adoption of point-of-care (POC) diagnostics is another critical driver of the Global Capillary Blood Collection Devices Market. Point-of-care testing allows for the rapid testing and analysis of blood samples outside of traditional laboratory settings, making it a convenient and timely solution for both healthcare providers and patients. In April 2023, Sensible Diagnostics revealed plans to introduce a point-of-care (POC) PCR instrument capable of delivering PCR results in just 10 minutes by 2024, initially focusing on infectious diseases. Additionally, Abbott launched ID NOW, the world's fastest molecular POC test, which provides COVID-19 results in 13 minutes and can be utilized in various healthcare settings, including doctor's offices and urgent care clinics. Furthermore, government initiatives aimed at controlling healthcare costs by limiting the growth of infectious disease incidence are expected to act as a key driver for this industry.

Capillary blood collection devices are central to POC diagnostics, especially for conditions that require quick results, such as diabetes, where patients need frequent blood glucose monitoring. POC testing enables immediate decision-making, making it especially beneficial in emergency situations and remote areas where access to labs may be limited. As healthcare providers seek to improve patient outcomes through faster diagnostic procedures, the demand for point-of-care devices is growing. The expansion of POC diagnostic offerings in areas like pharmacies, home healthcare, and ambulatory settings is fueling the adoption of capillary blood collection devices. This trend is expected to continue as POC diagnostic technology becomes more advanced, accurate, and affordable, further driving the market for capillary blood collection devices.

Increased Demand for Home Healthcare and Self-Monitoring

The growing demand for home healthcare and self-monitoring is another significant factor propelling the Global Capillary Blood Collection Devices Market. As patients become more informed and empowered, there is a growing preference for managing health conditions in the comfort of their homes. Capillary blood collection devices, which include devices for blood glucose monitoring, cholesterol testing, and hemoglobin monitoring, are increasingly being used in home healthcare settings. The convenience of at-home testing eliminates the need for patients to visit healthcare facilities regularly, reducing transportation costs and exposure to infections, especially in the post-COVID era. The advancement of telemedicine and mobile health apps that connect users with healthcare providers remotely has made self-monitoring even more feasible and attractive. With chronic conditions like diabetes requiring frequent monitoring, individuals now prefer to have easy-to-use, compact, and accurate blood collection devices that allow them to track their health status without the inconvenience of frequent doctor visits. The shift towards self-care and home monitoring is not just a response to global healthcare trends but also a means of empowering patients to take control of their health, leading to increased adoption of capillary blood collection devices. This trend is expected to continue growing as the world moves toward more patient-centric healthcare systems and remote monitoring solutions.

Segmental Insights

Product Insights

Based on the product, Lancets are currently the dominant segment. Lancets are small, sharp devices primarily used to puncture the skin to collect capillary blood for diagnostic testing, especially for glucose monitoring in diabetic patients. They account for the largest share of the market due to their simplicity, widespread use, and effectiveness in facilitating easy blood collection. Lancets are favored because they are minimally invasive and cause less discomfort compared to traditional venous blood collection methods, which often require needles and more extensive procedures. The ease of use is a significant factor contributing to their dominance, particularly in home healthcare settings. Lancets are used for routine blood tests like glucose monitoring, which is essential for individuals managing chronic conditions such as diabetes. With the growing global prevalence of diabetes and other chronic diseases that require regular monitoring, the demand for lancets has been steadily increasing, particularly in the self-care and home healthcare segments. Advancements in lancet technology, such as adjustable depth control and spring-loaded mechanisms for automatic activation, have improved patient comfort, making them even more attractive. These innovations have made lancets a convenient and cost-effective choice for both healthcare professionals and patients. The availability of lancets in various forms-single-use, multi-use, and automated devices-further enhances their appeal in the global market.

End Use Insights

Based on the end use segment, Hospitals & Clinics are the dominant segment. Hospitals and clinics have long been the primary settings for medical procedures, including blood collection, due to their established infrastructure, experienced healthcare professionals, and comprehensive diagnostic capabilities. The widespread use of capillary blood collection devices in hospitals and clinics is driven by the need for routine blood testing, particularly for chronic disease management, such as diabetes monitoring.

Hospitals and clinics are key players in the capillary blood collection devices market because they conduct a high volume of diagnostic tests, from glucose monitoring for diabetes patients to various other diagnostic tests requiring small blood samples. These healthcare facilities are at the forefront of patient care and diagnostic services, making them the primary consumers of lancets and other capillary blood collection devices. The demand for devices like lancets in hospitals is driven by the need for rapid, efficient blood collection methods that are minimally invasive and cost-effective. Healthcare professionals in hospitals and clinics frequently rely on capillary blood collection for patients who require frequent monitoring, such as those with diabetes, newborns requiring neonatal screening, and individuals undergoing pre-surgical tests. Hospitals and clinics are equipped with the necessary infrastructure, such as trained healthcare personnel, medical equipment, and laboratory facilities, to ensure efficient blood collection and analysis. These facilities offer both inpatient and outpatient care, leading to a high volume of blood collection procedures that use capillary blood collection devices. The integration of these devices into daily clinical practice has resulted in their widespread adoption, making them a significant part of the routine diagnostic process. As hospitals focus on improving patient outcomes, capillary blood collection devices are seen as an effective way to gather crucial diagnostic information in a quick and minimally invasive manner.

Regional Insights

North America was the dominant region in the Global Capillary Blood Collection Devices Market. This region leads the market due to several factors, including the high prevalence of chronic diseases, advanced healthcare infrastructure, a strong focus on self-monitoring, and the presence of major market players. North America, particularly the United States, has a well-established healthcare system that supports the widespread adoption of capillary blood collection devices, especially for conditions like diabetes, where regular blood glucose monitoring is crucial.

One of the key drivers of market dominance in North America is the high rate of chronic diseases, particularly diabetes. According to the Centers for Disease Control and Prevention (CDC), over 34 million people in the U.S. are living with diabetes, and approximately 88 million adults have prediabetes. This has led to an increasing demand for devices that can help manage and monitor blood glucose levels at home. Capillary blood collection devices, such as lancets and blood glucose meters, have become essential tools for self-monitoring, contributing to the growing adoption of these devices. The region's strong healthcare infrastructure also plays a critical role in market dominance. North America has a vast network of hospitals, clinics, diagnostic centers, and home healthcare services, all of which rely on capillary blood collection devices for routine blood testing and monitoring. Hospitals and healthcare providers in the U.S. and Canada frequently use lancets and other devices to conduct various diagnostic tests, further expanding the market. The widespread adoption of telemedicine and home healthcare services has fostered the growth of home diagnosis, with patients utilizing capillary blood collection devices for self-testing at home.

Key Market Players

  • Becton, Dickinson and Company
  • Greiner Bio-One International GmbH
  • Sarstedt Ag & Co. KG
  • Terumo Medical Corporation
  • B. Braun Melsungen AG
  • Guangzhou Improve Medical Instruments Co., Ltd
  • Abbott Laboratories Inc.
  • Cardinal Health, inc
  • Retractable Technologies, Inc.
  • Haemonetics Corporation

Report Scope:

In this report, the Global Capillary Blood Collection Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Capillary Blood Collection Devices Market, By Product:

  • Lancets
  • Micro-container Tubes
  • Micro-hematocrit Tubes
  • Warming Devices
  • Others

Capillary Blood Collection Devices Market, By Material:

  • Plastic
  • Glass
  • Stainless Steel
  • Ceramic
  • Others

Capillary Blood Collection Devices Market, By End Use:

  • Hospitals & Clinics
  • Blood Donation Centers
  • Diagnostic Centers
  • Home Diagnosis
  • Pathology Laboratories

Capillary Blood Collection Devices Market, By Application:

  • Whole Blood
  • Plasma/ Serum Protein Tests
  • Comprehensive Metabolic Panel (CMP) Tests
  • Liver Panel / Liver Profile/ Liver Function Tests
  • Dried Blood Spot Tests

Capillary Blood Collection Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Capillary Blood Collection Devices Market.

Available Customizations:

Global Capillary Blood Collection Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Capillary Blood Collection Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Lancets, Micro-container Tubes, Micro-hematocrit Tubes, Warming Devices, and Others)
    • 5.2.2. By Material (Plastic, Glass, Stainless Steel, Ceramic, and Others)
    • 5.2.3. By End Use (Hospitals & Clinics, Blood Donation Centers, Diagnostic Centers, Home Diagnosis, and Pathology Laboratories)
    • 5.2.4. By Application (Whole Blood, Plasma/ Serum Protein Tests, Comprehensive Metabolic Panel (CMP) Tests, Liver Panel / Liver Profile/ Liver Function Tests, and Dried Blood Spot Tests)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Capillary Blood Collection Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Material
    • 6.2.3. By End Use
    • 6.2.4. By Application
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Capillary Blood Collection Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Material
        • 6.3.1.2.3. By End Use
        • 6.3.1.2.4. By Application
    • 6.3.2. Canada Capillary Blood Collection Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Material
        • 6.3.2.2.3. By End Use
        • 6.3.2.2.4. By Application
    • 6.3.3. Mexico Capillary Blood Collection Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Material
        • 6.3.3.2.3. By End Use
        • 6.3.3.2.4. By Application

7. Europe Capillary Blood Collection Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Material
    • 7.2.3. By End Use
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Capillary Blood Collection Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Material
        • 7.3.1.2.3. By End Use
        • 7.3.1.2.4. By Application
    • 7.3.2. United Kingdom Capillary Blood Collection Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Material
        • 7.3.2.2.3. By End Use
        • 7.3.2.2.4. By Application
    • 7.3.3. Italy Capillary Blood Collection Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Material
        • 7.3.3.2.3. By End Use
        • 7.3.3.2.4. By Application
    • 7.3.4. France Capillary Blood Collection Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Material
        • 7.3.4.2.3. By End Use
        • 7.3.4.2.4. By Application
    • 7.3.5. Spain Capillary Blood Collection Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Material
        • 7.3.5.2.3. By End Use
        • 7.3.5.2.4. By Application

8. Asia-Pacific Capillary Blood Collection Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Material
    • 8.2.3. By End Use
    • 8.2.4. By Application
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Capillary Blood Collection Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Material
        • 8.3.1.2.3. By End Use
        • 8.3.1.2.4. By Application
    • 8.3.2. India Capillary Blood Collection Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Material
        • 8.3.2.2.3. By End Use
        • 8.3.2.2.4. By Application
    • 8.3.3. Japan Capillary Blood Collection Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Material
        • 8.3.3.2.3. By End Use
        • 8.3.3.2.4. By Application
    • 8.3.4. South Korea Capillary Blood Collection Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Material
        • 8.3.4.2.3. By End Use
        • 8.3.4.2.4. By Application
    • 8.3.5. Australia Capillary Blood Collection Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Material
        • 8.3.5.2.3. By End Use
        • 8.3.5.2.4. By Application

9. South America Capillary Blood Collection Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Material
    • 9.2.3. By End Use
    • 9.2.4. By Application
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Capillary Blood Collection Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Material
        • 9.3.1.2.3. By End Use
        • 9.3.1.2.4. By Application
    • 9.3.2. Argentina Capillary Blood Collection Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Material
        • 9.3.2.2.3. By End Use
        • 9.3.2.2.4. By Application
    • 9.3.3. Colombia Capillary Blood Collection Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Material
        • 9.3.3.2.3. By End Use
        • 9.3.3.2.4. By Application

10. Middle East and Africa Capillary Blood Collection Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Material
    • 10.2.3. By End Use
    • 10.2.4. By Application
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Capillary Blood Collection Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Material
        • 10.3.1.2.3. By End Use
        • 10.3.1.2.4. By Application
    • 10.3.2. Saudi Arabia Capillary Blood Collection Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Material
        • 10.3.2.2.3. By End Use
        • 10.3.2.2.4. By Application
    • 10.3.3. UAE Capillary Blood Collection Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Material
        • 10.3.3.2.3. By End Use
        • 10.3.3.2.4. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Becton, Dickinson and Company
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Greiner Bio-One International GmbH
  • 14.3. Sarstedt Ag & Co. KG
  • 14.4. Terumo Medical Corporation
  • 14.5. B. Braun Melsungen AG
  • 14.6. Guangzhou Improve Medical Instruments Co., Ltd
  • 14.7. Abbott Laboratories Inc.
  • 14.8. Cardinal Health, inc
  • 14.9. Retractable Technologies, Inc.
  • 14.10. Haemonetics Corporation

15. Strategic Recommendations

16. About Us & Disclaimer